Evidence map›Paper›PMID 37622862›Full record

ReviewBiosensors2023

Recent Advances of Metal-Polyphenol Coordination Polymers for Biomedical Applications.

Jing Qin, Ningning Guo, Jia Yang, Yong Chen

Abstract readReview
In one paragraph

Review in Biosensors, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Dual-modality immune nano-activator harnessing MnJournal of nanobiotechnology · 2025
    Article
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jing QinCollege of Advanced Materials Engineering, Jiaxing Nanhu University, Jiaxing 314001, China.
Ningning GuoCollege of Advanced Materials Engineering, Jiaxing Nanhu University, Jiaxing 314001, China.
Jia YangCollege of Advanced Materials Engineering, Jiaxing Nanhu University, Jiaxing 314001, China.
Yong ChenCollege of Advanced Materials Engineering, Jiaxing Nanhu University, Jiaxing 314001, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nanomedicine has provided cutting-edge technologies and innovative methods for modern biomedical research, offering unprecedented opportunities to tackle crucial biomedical issues. Nanomaterials with unique structures and properties can integrate multiple functions to achieve more precise diagnosis and treatment, making up for the shortcomings of traditional treatment methods. Among them, metal-polyphenol coordination polymers (MPCPs), composed of metal ions and phenolic ligands, are considered as ideal nanoplatforms for disease diagnosis and treatment. Recently, MPCPs have been extensively investigated in the field of biomedicine due to their facile synthesis, adjustable structures, and excellent biocompatibility, as well as pH-responsiveness. In this review, the classification of various MPCPs and their fabrication strategies are firstly summarized. Then, their significant achievements in the biomedical field such as biosensing, drug delivery, bioimaging, tumor therapy, and antibacterial applications are highlighted. Finally, the main limitations and outlooks regarding MPCPs are discussed.

Indexed as

PhenolsPolyphenolsAnti-Bacterial AgentsMetalsPolymersSuccinimidesAnti-Bacterial AgentsMetalsN-(3-methyl-2-pyridyl)-3-(4-chlorophenyl)succinimidePhenolsPolymersPolyphenolsSuccinimidesantibacterialbiomedicalmetal–phenolic coordination polymerspolyphenoltumor therapy

Identifiers

PMID37622862
PMCPMC10452320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.